Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma


Published: 29 December 2022
Abstract Views: 510
PDF: 281
HTML: 9
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Not available


Hao Z, Wang P. Lenvatinib in Management of Solid Tumors. Oncologist 2020; 25(2): e302-e310. DOI: 10.1634/theoncologist.2019-0407. DOI: https://doi.org/10.1634/theoncologist.2019-0407

Haddad RI, Schlumberger M, Wirth LJ et al. Incidence and timing of common adverse events in Lenvatinib treated patients from the SELECT trial and their association with survival outcomes. Endocrine 2017; 56(1): 121-128. DOI: 10.1007/s12020-017-1233-5. DOI: https://doi.org/10.1007/s12020-017-1233-5

Kudo M, Finn RS, Qin S et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 2018; 391(10126): 1163-1173. DOI: 10.1016/S0140-6736(18)30207-1. DOI: https://doi.org/10.1016/S0140-6736(18)30207-1

Iwamoto H, Suzuki H, Shimose S et al. Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability toward Adverse Events. Cancers (Basel) 2020; 12(4). DOI: 10.3390/cancers12041010. DOI: https://doi.org/10.3390/cancers12041010

Ikeda M, Fujita T, Mii S et al. Erythema multiforme induced by sorafenib for metastatic renal cell carcinoma. Jpn J Clin Oncol 2012; 42(9): 820-824. DOI: 10.1093/jjco/hys103. DOI: https://doi.org/10.1093/jjco/hys103

Matsumoto, Y., Fukumoto, T., Takahashi, W., & Nishigori, C. (2022). Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma. Dermatology Reports, 15(2). https://doi.org/10.4081/dr.2023.9617

Downloads

Download data is not yet available.

Citations